Ulaeto D , Agafonov A , Burchfield J , Carter L , Happi C , Jakob R , et al . New nomenclature for mpox (monkeypox) and monkeypox virus clades . Lancet Infect Dis . 2023 ; 23 ( 3 ): 273 – 5 .

Li H , Zhang H , Ding K , Wang XH , Sun GY , Liu ZX , et al . The evolving epidemiology of monkeypox virus . Cytokine Growth Factor Rev . 2022 ; 68 : 1 – 12 .

Farasani A . Monkeypox virus: future role in human population . J Infect Public Health . 2022 ; 15 ( 11 ): 1270 – 5 .

Otieno JR , Ruis C , Onoja AB , Kuppalli K , Hoxha A , Nitsche A , et al . Global genomic surveillance of monkeypox virus . Nat Med . 2025 ; 31 ( 1 ): 342 – 50 .

Gigante CM , Korber B , Seabolt MH , Wilkins K , Davidson W , Rao AK , et al . Multiple lineages of monkeypox virus detected in the United States, 2021–2022 . Science . 2022 ; 378 ( 6619 ): 560 – 5 .

Ndodo N , Ashcroft J , Lewandowski K , Yinka‑Ogunleye A , Chukwu C , Ahmad A , et al . Distinct monkeypox virus lineages co‑circulating in humans before 2022 . Nat Med . 2023 ; 29 ( 9 ): 2317 – 24 .

Isidro J , Borges V , Pinto M , Sobral D , Santos JD , Nunes A , et al . Phylog‑enomic characterization and signs of microevolution in the 2022 multi‑country outbreak of monkeypox virus . Nat Med . 2022 ; 28 ( 8 ): 1569 – 72 .

Scarpa F , Sanna D , Azzena I , Cossu P , Locci C , Angeletti S , et al . Genetic variability of the monkeypox virus clade IIb B.1 . J Clin Med . 2022 ; 11 ( 21 ): 6388 .

Nuzzo JB , Borio LL , Gostin LO . The WHO declaration of monkeypox as a global public health emergency . JAMA . 2022 ; 328 ( 7 ): 615 – 7 .

Gessain A , Nakoune E , Yazdanpanah Y . Monkeypox . N Engl J Med . 2022 ; 387 ( 19 ): 1783 – 93 .

Wawina‑Bokalanga T , Akil‑Bandali P , Kinganda‑Lusamaki E , Lokilo E , Jansen D , Amuri‑Aziza A , et al . Co‑circulation of monkeypox virus subclades Ia and Ib in Kinshasa Province, democratic republic of the Congo, July to August 2024 . Euro Surveill . 2024 ; 29 ( 38 ): 2400592 .

Eurosurveillance Editorial Team . Note from the editors: WHO declares mpox outbreak a public health emergency of international concern . Euro Surveill . 2024 ; 29 ( 33 ): 240815v .

WHO director‑general declares mpox outbreak a public health emer‑gency of international concern . Saudi Med J . 2024 ; 45 ( 9 ): 1002–03 .

Zhang Z , Jiang H , Jiang S , Dong T , Wang X , Wang Y , et al . Rapid detec‑tion of the monkeypox virus genome and antigen proteins based on surface‑enhanced Raman spectroscopy . ACS Appl Mater Interfaces . 2023 ; 15 ( 29 ): 34419 – 26 .

Huo S , Chen Y , Lu R , Zhang Z , Zhang G , Zhao L , et al . Development of 2 multiplex real‑time PCR assays for simultaneous detection and dif‑ferentiation of monkeypox virus IIa, IIb, and I clades and the B.1 lineage . Biosaf Health . 2022 ; 4 ( 6 ): 392 – 8 .

Lu T , Wu Z , Jiang S , Lu L , Liu H . The current emergence of monkeypox: The recurrence of another smallpox? Biosaf Health . 2022 ; 4 ( 6 ): 369 – 75 .

Lim CK , Roberts J , Moso M , Liew KC , Taouk ML , Williams E , et al . Monk‑eypox diagnostics: review of current and emerging technologies . J Med Virol . 2023 ; 95 ( 1 ): e28429 .

McCollum AM , Damon IK . Human monkeypox . Clin Infect Dis . 2014 ; 58 ( 2 ): 260 – 7 .

Fine PE , Jezek Z , Grab B , Dixon H . The transmission potential of monkey‑pox virus in human populations . Int J Epidemiol . 1988 ; 17 ( 3 ): 643 – 50 .

Gruber MF . Current status of monkeypox vaccines . NPJ Vaccines . 2022 ; 7 ( 1 ): 94 .

Kandeel M , Morsy MA , Abd El‑Lateef HM , Marzok M , El‑Beltagi HS , Al Khodair KM , et al . Efficacy of the modified vaccinia Ankara virus vaccine and the replication‑competent vaccine ACAM2000 in monkeypox prevention . Int Immunopharmacol . 2023 ; 119 : 110206 .

Hazra A , Rusie L , Hedberg T , Schneider JA . Human monkeypox virus infection in the immediate period after receiving modified vaccinia ankara vaccine . JAMA . 2022 ; 328 ( 20 ): 2064 – 7 .

Sang Y , Zhang Z , Liu F , Lu H , Yu C , Sun H , et al . Monkeypox virus quad‑rivalent mRNA vaccine induces immune response and protects against vaccinia virus . Signal Transduct Target Ther . 2023 ; 8 ( 1 ): 172 .

Zaeck LM , Lamers MM , Verstrepen BE , Bestebroer TM , van Royen ME , Götz H , et al . Low levels of monkeypox virus‑neutralizing antibod‑ies after MVA‑BN vaccination in healthy individuals . Nat Med . 2023 ; 29 ( 1 ): 270 – 8 .

Rizk JG , Lippi G , Henry BM , Forthal DN , Rizk Y . Prevention and treatment of monkeypox . Drugs . 2022 ; 82 ( 9 ): 957 – 63 .

Huston J , Curtis S , Egelund EF . Brincidofovir: a novel agent for the treat‑ment of smallpox . Ann Pharmacother . 2023 ; 57 ( 10 ): 1198 – 206 .

Hoy SM . Tecovirimat: first global approval . Drugs . 2018 ; 78 ( 13 ): 1377 – 82 .

Alakunle E , Kolawole D , Diaz‑Cánova D , Alele F , Adegboye O , Moens U , et al . A comprehensive review of monkeypox virus and monkeypox characteristics . Front Cell Infect Microbiol . 2024 ; 14 : 1360586 .

Lim EY , Whitehorn J , Rivett L . Monkeypox: a review of the 2022 out‑break . Br Med Bull . 2023 ; 145 ( 1 ): 17 – 29 .

Wang L , Shang J , Weng S , Aliyari SR , Ji C , Cheng G , et al . Genomic anno‑tation and molecular evolution of monkeypox virus outbreak in 2022 . J Med Virol . 2023 ; 95 ( 1 ): e28036 .

Smith TG , Gigante CM , Wynn NT , Matheny A , Davidson W , Yang Y , et al . Tecovirimat resistance in monkeypox patients, United States, 2022–2023 . Emerg Infect Dis . 2023 ; 29 ( 12 ): 2426 – 32 .

Mitjà O , Alemany A , Marks M , Lezama Mora JI , Rodríguez‑Aldama JC , Torres Silva MS , et al . monkeypox in people with advanced HIV infec‑tion: a global case series . Lancet . 2023 ; 401 ( 10380 ): 939 – 49 .

Andrei G , Snoeck R . Differences in pathogenicity among the monkey‑pox virus clades: impact on drug discovery and vaccine development . Trends Pharmacol Sci . 2023 ; 44 ( 10 ): 719 – 39 .

Zhang Y , Zhang JY , Wang FS . Monkeypox outbreak: a novel threat after COVID‑19? . Mil Med Res . 2022 ; 9 ( 1 ): 29 .

Denkinger CM , Janssen M , Schäkel U , Gall J , Leo A , Stelmach P , et al . Anti‑SARS‑CoV‑2 antibody‑containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID‑19: a randomized clinical trial . Nat Cancer . 2023 ; 4 ( 1 ): 96 – 107 .

Marconato M , Abela IA , Hauser A , Schwarzmüller M , Katzensteiner R , Braun DL , et al . Antibodies from convalescent plasma promote SARS‑CoV‑2 clearance in individuals with and without endogenous antibody response . J Clin Invest . 2022 ; 132 ( 12 ): e158190 .

Klasse PJ , Moore JP . Antibodies to SARS‑CoV‑2 and their potential for therapeutic passive immunization . Elife . 2020 ; 9 : e57877 .

Caskey M , Klein F , Nussenzweig MC . Broadly neutralizing anti‑HIV‑1 monoclonal antibodies in the clinic . Nat Med . 2019 ; 25 ( 4 ): 547 – 53 .

Li M , Wang Y , Li C , Xu R , Chen J , Zhang J , et al . Development of mono‑clonal antibody‑based antigen detection assays for orthopoxvirus and monkeypox virus . J Infect . 2022 ; 85 ( 6 ): 702 – 69 .

Zuiani A , Dulberger CL , De Silva NS , Marquette M , Lu YJ , Palowitch GM , et al . A multivalent mRNA monkeypox virus vaccine (BNT166)protects mice and macaques from orthopoxvirus disease . Cell . 2024 ; 187 ( 6 ): 1363 – 73.e12 .

Lederman ER , Davidson W , Groff HL , Smith SK , Warkentien T , Li Y , et al . Progressive vaccinia: case description and laboratory‑guided therapy with vaccinia immune globulin, ST‑246, and CMX001 . J Infect Dis . 2012 ; 206 ( 9 ): 1372 – 85 .

Lu J , Xing H , Wang C , Tang M , Wu C , Ye F , et al . Monkeypox (formerly monkeypox): pathogenesis, prevention, and treatment . Signal Trans‑duct Target Ther . 2023 ; 8 ( 1 ): 458 .

Shi D , He P , Song Y , Cheng S , Linhardt RJ , Dordick JS , et al . Kinetic and structural aspects of glycosaminoglycan‑monkeypox virus protein A29 interactions using surface plasmon resonance . Molecules . 2022 ; 27 ( 18 ): 5898 .

Lin CL , Chung CS , Heine HG , Chang W . Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intra‑cellular mature virion morphogenesis and virus infection in vitro and in vivo . J Virol . 2000 ; 74 ( 7 ): 3353 – 65 .

Hsiao JC , Chung CS , Chang W . Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells . J Virol . 1999 ; 73 ( 10 ): 8750 – 61 .

Bisht H , Weisberg AS , Moss B . Vaccinia virus l1 protein is required for cell entry and membrane fusion . J Virol . 2008 ; 82 ( 17 ): 8687 – 94 .

Unger B , Traktman P . Vaccinia virus morphogenesis: A13 phos‑phoprotein is required for assembly of mature virions . J Virol . 2004 ; 78 ( 16 ): 8885 – 901 .

Monticelli SR , Earley AK , Stone R , Norbury CC , Ward BM . Vaccinia virus glycoproteins A33, A34, and B5 form a complex for efficient endoplasmic reticulum to trans‑golgi network transport . J Virol . 2020 ; 94 ( 7 ): e02155 – 219 .

Crickard L , Babas T , Seth S , Silvera P , Koriazova L , Crotty S . Protection of rabbits and immunodeficient mice against lethal poxvirus infections by human monoclonal antibodies . PLoS ONE . 2012 ; 7 ( 11 ): e48706 .

Tamir H , Noy‑Porat T , Melamed S , Cherry‑Mimran L , Barlev‑Gross M , Alcalay R , et al . Synergistic effect of 2 human‑like monoclonal antibod‑ies confers protection against orthopoxvirus infection . Nat Commun . 2024 ; 15 ( 1 ): 3265 .

Esqueda A , Sun H , Bonner J , Lai H , Jugler C , Kibler KV , et al . A monoclo‑nal antibody produced in glycoengineered plants potently neutralizes monkeypox virus . Vaccines . 2023 ; 11 ( 7 ): 1179 .

Zeng J , Li Y , Jiang L , Luo L , Wang Y , Wang H , et al . Monkeypox multi‑antigen mRNA vaccine candidates by a simplified manufacturing strat‑egy afford efficient protection against lethal orthopoxvirus challenge . Emerg Microbes Infect . 2023 ; 12 ( 1 ): 2204151 .

Xu C , Meng X , Yan B , Crotty S , Deng J , Xiang Y . An epitope conserved in orthopoxvirus A13 envelope protein is the target of neutralizing and protective antibodies . Virology . 2011 ; 418 ( 1 ): 67 – 73 .

Li M , Ren Z , Wang Y , Jiang Y , Yang M , Li D , et al . Three neutralizing mabs induced by MPXV A29L protein recognizing different epitopes act synergistically against orthopoxvirus . Emerg Microbes Infect . 2023 ; 12 ( 2 ): 2223669 .

Meng N , Cheng X , Sun M , Zhang Y , Sun X , Liu X , et al . Screening, expres‑sion and identification of nanobody against monkeypox virus A35R . Int J Nanomedicine . 2023 ; 18 : 7173 – 81 .

Zhao R , Wu L , Sun J , Liu D , Han P , Gao Y , et al . Two noncompeting human neutralizing antibodies targeting MPXV B6 show protective effects against orthopoxvirus infections . Nat Commun . 2024 ; 15 ( 1 ): 4660 .

Moss B . Membrane fusion during poxvirus entry . Semin Cell Dev Biol . 2016 ; 60 : 89 – 96 .

Al‑Kuraishy HM , Al‑Gareeb AI , Hetta HF , Alexiou A , Papadakis M , Batiha GE . Monkeypox epidemic at the door: should we remain idly by or prepare strongly? . AMB Express . 2023 ; 13 ( 1 ): 5 .

Foo CH , Lou H , Whitbeck JC , Ponce‑de‑León M , Atanasiu D , Eisenberg RJ , et al . Vaccinia virus L1 binds to cell surfaces and blocks virus entry independently of glycosaminoglycans . Virology . 2009 ; 385 ( 2 ): 368 – 82 .

Carter GC , Law M , Hollinshead M , Smith GL . Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans . J Gen Virol . 2005 ; 86 ( Pt 5 ): 1279 – 90 .

Wang Y , Yang K , Zhou H . Immunogenic proteins and potential delivery platforms for monkeypox virus vaccine development: a rapid review . Int J Biol Macromol . 2023 ; 245 : 125515 .

Schmidt FI , Bleck CK , Helenius A , Mercer J . Vaccinia extracellular virions enter cells by macropinocytosis and acid‑activated membrane rupture . Embo J . 2011 ; 30 ( 17 ): 3647 – 61 .

Roberts KL , Breiman A , Carter GC , Ewles HA , Hollinshead M , Law M , et al . Acidic residues in the membrane‑proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan‑mediated disrup‑tion of the extracellular enveloped virus outer membrane . J Gen Virol . 2009 ; 90 ( Pt 7 ): 1582 – 91 .

Law M , Carter GC , Roberts KL , Hollinshead M , Smith GL . Ligand‑induced and nonfusogenic dissolution of a viral membrane . Proc Natl Acad Sci USA . 2006 ; 103 ( 15 ): 5989 – 94 .

Lant S , Maluquer de Motes C . Poxvirus interactions with the host ubiq‑uitin system . Pathogens . 2021 ; 10 ( 8 ): 1034 .

Mercer J , Snijder B , Sacher R , Burkard C , Bleck CK , Stahlberg H , et al . RNAi screening reveals proteasome‑ and cullin3‑dependent stages in vaccinia virus infection . Cell Rep . 2012 ; 2 ( 4 ): 1036 – 47 .

Liu L , Cooper T , Howley PM , Hayball JD . From crescent to mature virion: vaccinia virus assembly and maturation . Viruses . 2014 ; 6 ( 10 ): 3787 – 808 .

Maruri‑Avidal L , Weisberg AS , Moss B . Direct formation of vaccinia virus membranes from the endoplasmic reticulum in the absence of the newly characterized L2‑interacting protein A30.5 . J Virol . 2013 ; 87 ( 22 ): 12313 – 26 .

Tolonen N , Doglio L , Schleich S , Krijnse LJ . Vaccinia virus DNA replication occurs in endoplasmic reticulum‑enclosed cytoplasmic mini‑nuclei . Mol Biol Cell . 2001 ; 12 ( 7 ): 2031 – 46 .

Breiman A , Carpentier DCJ , Ewles HA , Smith GL . Transport and stability of the vaccinia virus A34 protein is affected by the A33 protein . J Gen Virol . 2013 ; 94 ( Pt 4 ): 720 – 5 .

Perdiguero B , Blasco R . Interaction between vaccinia virus extracellular virus envelope A33 and B5 glycoproteins . J Virol . 2006 ; 80 ( 17 ): 8763 – 77 .

Abebaw D , Akelew Y , Adugna A , Teffera ZH , Tegegne BA , Fenta A , et al . Antigen recognition and immune response to monkeypox virus infec‑tion: implications for monkeypox vaccine design—a narrative review . Infez Med . 2025 ; 33 ( 2 ): 151 – 62 .

Croft NP , Smith SA , Wong YC , Tan CT , Dudek NL , Flesch IE , et al . Kinetics of antigen expression and epitope presentation during virus infection . PLoS Pathog . 2013 ; 9 ( 1 ): e1003129 .

Serna A , Ramirez MC , Soukhanova A , Sigal LJ . Cutting edge: Efficient MHC class I cross‑presentation during early vaccinia infection requires the transfer of proteasomal intermediates between antigen donor and presenting cells . J Immunol . 2003 ; 171 ( 11 ): 5668 – 72 .

Thiele F , Tao S , Zhang Y , Muschaweckh A , Zollmann T , Protzer U , et al . Modified vaccinia virus ankara‑infected dendritic cells present CD4 + T‑cell epitopes by endogenous major histocompatibility complex class II presentation pathways . J Virol . 2015 ; 89 ( 5 ): 2698 – 709 .

Lum FM , Torres‑Ruesta A , Tay MZ , Lin RTP , Lye DC , Rénia L , et al . Monk‑eypox: disease epidemiology, host immunity and clinical interventions . Nat Rev Immunol . 2022 ; 22 ( 10 ): 597 – 613 .

Song H , Josleyn N , Janosko K , Skinner J , Reeves RK , Cohen M , et al . Mon‑keypox virus infection of rhesus macaques induces massive expansion of natural killer cells but suppresses natural killer cell functions . PLoS ONE . 2013 ; 8 ( 10 ): e77804 .

MacLeod MK , Clambey ET , Kappler JW , Marrack P . CD4 memory T cells: What are they and what can they do? . Semin Immunol . 2009 ; 21 ( 2 ): 53 – 61 .

Edghill‑Smith Y , Golding H , Manischewitz J , King LR , Scott D , Bray M , et al . Smallpox vaccine‑induced antibodies are necessary and sufficient for protection against monkeypox virus . Nat Med . 2005 ; 11 ( 7 ): 740 – 7 .

Hickman HD , Reynoso GV , Ngudiankama BF , Rubin EJ , Magadán JG , Cush SS , et al . Anatomically restricted synergistic antiviral activities of innate and adaptive immune cells in the skin . Cell Host Microbe . 2013 ; 13 ( 2 ): 155 – 68 .

Kennedy RB , Ovsyannikova IG , Jacobson RM , Poland GA . The immunol‑ogy of smallpox vaccines . Curr Opin Immunol . 2009 ; 21 ( 3 ): 314 – 20 .

Grifoni A , Zhang Y , Tarke A , Sidney J , Rubiro P , Reina‑Campos M , et al . Defining antigen targets to dissect vaccinia virus and monk‑eypox virus‑specific T cell responses in humans . Cell Host Microbe . 2022 ; 30 ( 12 ): 1662 – 70.e4 .

Alzhanova D , Hammarlund E , Reed J , Meermeier E , Rawlings S , Ray CA , et al . T cell inactivation by poxviral B22 family proteins increases viral virulence . PLoS Pathog . 2014 ; 10 ( 5 ): e1004123 .

Li H , Huang QZ , Zhang H , Liu ZX , Chen XH , Ye LL , et al . The land‑scape of immune response to monkeypox virus . EBioMedicine . 2023 ; 87 : 104424 .

Saghazadeh A , Rezaei N . Poxviruses and the immune system: impli‑cations for monkeypox virus . Int Immunopharmacol . 2022 ; 113 ( Pt A ): 109364 .

Karem KL , Reynolds M , Hughes C , Braden Z , Nigam P , Crotty S , et al . Monkeypox‑induced immunity and failure of childhood smallpox vaccination to provide complete protection . Clin Vaccine Immunol . 2007 ; 14 ( 10 ): 1318 – 27 .

Gilchuk I , Gilchuk P , Sapparapu G , Lampley R , Singh V , Kose N , et al . Cross‑neutralizing and protective human antibody specificities to poxvirus infections . Cell . 2016 ; 167 ( 3 ): 684 – 94.e9 .

Brown JN , Estep RD , Lopez‑Ferrer D , Brewer HM , Clauss TR , Manes NP , et al . Characterization of macaque pulmonary fluid proteome during monkeypox infection: dynamics of host response . Mol Cell Proteomics . 2010 ; 9 ( 12 ): 2760 – 71 .

Liszewski MK , Leung MK , Hauhart R , Buller RM , Bertram P , Wang X , et al . Structure and regulatory profile of the monkeypox inhibitor of comple‑ment: comparison to homologs in vaccinia and variola and evidence for dimer formation . J Immunol . 2006 ; 176 ( 6 ): 3725 – 34 .

Ghate SD , Suravajhala P , Patil P , Vangala RK , Shetty P , Rao RSP . Molecular detection of monkeypox and related viruses: challenges and opportu‑nities . Virus Genes . 2023 ; 59 ( 3 ): 343 – 50 .

Langer J , Jimenez de Aberasturi D , Aizpurua J , Alvarez‑Puebla RA , Auguié B , Baumberg JJ , et al . Present and future of surface‑enhanced raman scattering . ACS Nano . 2020 ; 14 ( 1 ): 28 – 117 .

Babu PJ , Tirkey A , Paul AA , Kristollari K , Barman J , Panda K , et al . Advances in nano silver‑based biomaterials and their biomedical appli‑cations . Eng Regen . 2024 ; 5 ( 3 ): 326 – 41 .

Awiaz G , Lin J , Wu A . Recent advances of Au@Ag core‑shell SERS‑based biosensors . Exploration . 2023 ; 3 ( 1 ): 20220072 .

Sun H , Miao Y , Yang X , Guo L , Li Q , Wang J , et al . Rapid identification of A29l antibodies based on mrna immunization and high‑throughput single B cell sequencing to detect monkeypox virus . Emerg Microbes Infect . 2024 ; 13 ( 1 ): 2332665 .

Townsend MB , MacNeil A , Reynolds MG , Hughes CM , Olson VA , Damon IK , et al . Evaluation of the tetracore orthopox biothreat ® antigen detec‑tion assay using laboratory‑grown orthopoxviruses and rash illness clinical specimens . J Virol Methods . 2013 ; 187 ( 1 ): 37 – 42 .

Ye L , Lei X , Xu X , Xu L , Kuang H , Xu C . Gold‑based paper for antigen detection of monkeypox virus . Analyst . 2023 ; 148 ( 5 ): 985 – 94 .

Yu Q , Li J , Zheng S , Xia X , Xu C , Wang C , et al . Molybdenum disulfide‑loaded multilayer aunps with colorimetric‑sers dual‑signal enhance‑ment activities for flexible immunochromatographic diagnosis of monkeypox virus . J Hazard Mater . 2023 ; 459 : 132136 .

Yan H , Su J , Tian L , Li Q , Feng X , Zhang J , et al . A rapid and sensitive fluorescent chromatography with cloud system for mpxv point‑of‑care diagnosis . Anal Chim Acta . 2024 ; 1302 : 342514 .

Wang W , Wang J , Hu Z , Yan X , Gao Q , Li X , et al . Advancing aggregation‐induced emission‐derived biomaterials in viral, tuberculosis, and fungal infectious diseases . Aggregate . 2024 .

Li Y , Cui Z , Huang L , Zhang D , Shen Y , Cheng J , et al . Aggregation‑based analytical chemistry in point‑of‑care nanosensors . Aggregate . 2024 ; 5 ( 5 ): e559 .

Shu J , Li Y , Cai H , Fu Q , Li C , Yuan J , et al . Ultrabright nir aiegen nano‑particles‑enhanced lateral flow immunoassay platform for accurate diagnostics of complex samples . Aggregate . 2024 ; 5 ( 4 ): e551 .

Yang X , Cheng X , Wei H , Tu Z , Rong Z , Wang C , et al . Fluorescence‑enhanced dual signal lateral flow immunoassay for flexible and ultrasensitive detection of monkeypox virus . J Nanobiotechnol . 2023 ; 21 ( 1 ): 450 .

Chandran M , Chellasamy G , Veerapandian M , Dhanasekaran B , Kumar Arumugasamy S , Govindaraju S , et al . Fabrication of label‑free immuno‑probe for monkeypox A29 detection using one‑step electrodeposited molybdenum oxide‑graphene quantum rods . J Colloid Interface Sci . 2024 ; 660 : 412 – 22 .

de Lima LF , Barbosa PP , Simeoni CL , de Paula RFO , Proenca‑Modena JL , de Araujo WR . Electrochemical paper‑based nanobiosensor for rapid and sensitive detection of monkeypox virus . ACS Appl Mater Interfaces . 2023 ; 15 ( 50 ): 58079 – 91 .

Fan Z , Liu Y , Ye Y , Liao Y . Functional probes for the diagnosis and treat‑ment of infectious diseases . Aggregate . 2024 ; 5 ( 6 ): e620 .

Han C , Liu Q , Luo X , Zhao J , Zhang Z , He J , et al . Development of a CRISPR/Cas12a‑mediated aptasensor for mpox virus antigen detection . Biosens Bioelectron . 2024 ; 257 : 116313 .

Cai S , Ren R , He J , Wang X , Zhang Z , Luo Z , et al . Selective single‑molecule nanopore detection of monkeypox A29 protein directly in biofluids . Nano Lett . 2023 ; 23 ( 24 ): 11438 – 46 .

Organization WH , Target product profiles for tests used for monkeypox (monkeypox) diagnosis . World Health Organization : 2023 .

Trivedi J , Yasir M , Maurya RK , Tripathi AS . Aptamer‑based theranostics in oncology: design strategies and limitations . BIO Integr . 2024 ; 5 ( 1 ): 1 – 20 .

Li T , Qian C , Gu Y , Zhang J , Li S , Xia N . Current progress in the devel‑opment of prophylactic and therapeutic vaccines . Sci China Life Sci . 2023 ; 66 ( 4 ): 679 – 710 .

Poria R , Kala D , Nagraik R , Dhir Y , Dhir S , Singh B , et al . Vaccine devel‑opment: current trends and technologies . Life Sci . 2024 ; 336 : 122331 .

Bartlett BL , Pellicane AJ , Tyring SK . Vaccine immunology . Dermatol Ther . 2009 ; 22 ( 2 ): 104 – 9 .

Delany I , Rappuoli R , De Gregorio E . Vaccines for the 21st century . EMBO Mol Med . 2014 ; 6 ( 6 ): 708 – 20 .

Poland GA , Kennedy RB , Tosh PK . Prevention of monkeypox with vac‑cines: a rapid review . Lancet Infect Dis . 2022 ; 22 ( 12 ): e349 – 58 .

Lozano JM , Muller S . Monkeypox: potential vaccine development strategies . Trends Pharmacol Sci . 2023 ; 44 ( 1 ): 15 – 9 .

Garcia‑Atutxa I , Mondragon‑Teran P , Huerta‑Saquero A , Villanueva‑Flores F . Advancements in monkeypox vaccines development: a critical review of emerging technologies . Front Immunol . 2024 ; 15 : 1456060 .

Rothenburg S , Yang Z , Beard P , Sawyer SL , Titanji B , Gonsalves G , et al . Monkeypox emergency: urgent questions and perspectives . Cell . 2022 ; 185 ( 18 ): 3279 – 81 .

Schmidt FI , Bleck CK , Mercer J . Poxvirus host cell entry . Curr Opin Virol . 2012 ; 2 ( 1 ): 20 – 7 .

Van Vliet K , Mohamed MR , Zhang L , Villa NY , Werden SJ , Liu J , et al . Poxvirus proteomics and virus‑host protein interactions . Microbiol Mol Biol Rev . 2009 ; 73 ( 4 ): 730 – 49 .

Weaver JR , Isaacs SN . Monkeypox virus and insights into its immu‑nomodulatory proteins . Immunol Rev . 2008 ; 225 : 96 – 113 .

Papukashvili D , Rcheulishvili N , Liu C , Wang X , He Y , Wang PG . Strat‑egy of developing nucleic acid‑based universal monkeypox vaccine candidates . Front Immunol . 2022 ; 13 : 1050309 .

Keasey S , Pugh C , Tikhonov A , Chen G , Schweitzer B , Nalca A , et al . Proteomic basis of the antibody response to monkeypox virus infection examined in cynomolgus macaques and a comparison to human smallpox vaccination . PLoS ONE . 2010 ; 5 ( 12 ): e15547 .

Moss B . Poxvirus cell entry: How many proteins does it take? . Viruses . 2012 ; 4 ( 5 ): 688 – 707 .

Galmiche MC , Goenaga J , Wittek R , Rindisbacher L . Neutralizing and protective antibodies directed against vaccinia virus envelope antigens . Virology . 1999 ; 254 ( 1 ): 71 – 80 .

Lai CF , Gong SC , Esteban M . The purified 14‑kilodalton envelope protein of vaccinia virus produced in escherichia coli induces virus immunity in animals . J Virol . 1991 ; 65 ( 10 ): 5631 – 5 .

Lustig S , Fogg C , Whitbeck JC , Eisenberg RJ , Cohen GH , Moss B . Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge . J Virol . 2005 ; 79 ( 21 ): 13454 – 62 .

Hooper JW , Custer DM , Thompson E . Four‑gene‑combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates . Virology . 2003 ; 306 ( 1 ): 181 – 95 .

Zhang Y , Zhou Y , Pei R , Chen X , Wang Y . Potential threat of human pathogenic orthopoxviruses to public health and control strategies . J Biosaf Biosecur . 2023 ; 5 ( 1 ): 1 – 7 .

Hooper JW , Custer DM , Schmaljohn CS , Schmaljohn AL . DNA vaccina‑tion with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge . Virology . 2000 ; 266 ( 2 ): 329 – 39 .

Fogg C , Lustig S , Whitbeck JC , Eisenberg RJ , Cohen GH , Moss B . Protec‑tive immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions . J Virol . 2004 ; 78 ( 19 ): 10230 – 7 .

Hooper JW , Thompson E , Wilhelmsen C , Zimmerman M , Ichou MA , Steffen SE , et al . Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox . J Virol . 2004 ; 78 ( 9 ): 4433 – 43 .

Hooper JW , Golden JW , Ferro AM , King AD . Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge . Vaccine . 2007 ; 25 ( 10 ): 1814 – 23 .

Hirao LA , Draghia‑Akli R , Prigge JT , Yang M , Satishchandran A , Wu L , et al . Multivalent smallpox DNA vaccine delivered by intradermal elec‑troporation drives protective immunity in nonhuman primates against lethal monkeypox challenge . J Infect Dis . 2011 ; 203 ( 1 ): 95 – 102 .

Brown E , Senkevich TG , Moss B . Vaccinia virus F9 virion membrane protein is required for entry but not virus assembly, in contrast to the related L1 protein . J Virol . 2006 ; 80 ( 19 ): 9455 – 64 .

Davies DH , McCausland MM , Valdez C , Huynh D , Hernandez JE , Mu Y , et al . Vaccinia virus h3l envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice . J Virol . 2005 ; 79 ( 18 ): 11724 – 33 .

Freyn AW , Atyeo C , Earl PL , Americo JL , Chuang GY , Natarajan H , et al . An mpox virus mRNA‑lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge . Sci Transl Med . 2023 ; 15 ( 716 ): eadg3540 .

Mucker EM , Freyn AW , Bixler SL , Cizmeci D , Atyeo C , Earl PL , et al . Comparison of protection against monkeypox following mRNA or modified vaccinia ankara vaccination in nonhuman primates . Cell . 2024 ; 187 ( 20 ): 5540 – 53.e10 .

Zhang RR , Wang ZJ , Zhu YL , Tang W , Zhou C , Zhao SQ , et al . Rational development of multicomponent mRNA vaccine candidates against monkeypox . Emerg Microbes Infect . 2023 ; 12 ( 1 ): 2192815 .

Zhang N , Cheng X , Zhu Y , Mo O , Yu H , Zhu L , et al . Multivalent mRNA vaccines against monkeypox enveloped or mature viron surface anti‑gens demonstrate robust immune response and neutralizing activity . Sci China Life Sci . 2023 ; 66 ( 10 ): 2329 – 41 .

Hou F , Zhang Y , Liu X , Murad YM , Xu J , Yu Z , et al . mRNA vaccines encod‑ing fusion proteins of monkeypox virus antigens protect mice from vaccinia virus challenge . Nat Commun . 2023 ; 14 ( 1 ): 5925 .

Fang Z , Monteiro VS , Renauer PA , Shang X , Suzuki K , Ling X , et al . Polyva‑lent mrna vaccination elicited potent immune response to monkeypox virus surface antigens . Cell Res . 2023 ; 33 ( 5 ): 407 – 10 .

Ye T , Zhou J , Guo C , Zhang K , Wang Y , Liu Y , et al . Polyvalent monkeypox mRNA vaccines elicit robust immune responses and confer potent protection against vaccinia virus . Cell Rep . 2024 ; 43 ( 6 ): 114269 .

Yang X , Hu C , Yang X , Yang X , Hu X , Wang X , et al . Evaluation and com‑parison of immune responses induced by 2 monkeypox mRNA vaccine candidates in mice . J Med Virol . 2023 ; 95 ( 10 ): e29140 .

Su C , Li S , Wen Y , Geng X , Yin Q , Wang Y , et al . A quadrivalent mRNA immunization elicits potent immune responses against multiple orthopoxviral antigens and neutralization of monkeypox virus in rodent models . Vaccines . 2024 ; 12 ( 4 ): 385 .

Hendrickson RC , Wang C , Hatcher EL , Lefkowitz EJ . Orthopoxvirus genome evolution: the role of gene loss . Viruses . 2010 ; 2 ( 9 ): 1933 – 67 .

Fenner F , Wittek R , Dumbell K . The pathogenesis, pathology, and immu‑nology of orthopoxvirus infections . The Orthopoxviruses . 1989 : 85 – 141 .

Cheng F , Wang Y , Bai Y , Liang Z , Mao Q , Liu D , et al . Research advances on the stability of mRNA vaccines . Viruses . 2023 ; 15 ( 3 ): 668 .

Guasp P , Reiche C , Sethna Z , Balachandran VP . RNA vaccines for cancer: principles to practice . Cancer Cell . 2024 ; 42 ( 7 ): 1163 – 84 .

Greenberg RN , Overton ET , Haas DW , Frank I , Goldman M , von Krem‑pelhuber A , et al . Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia ankara as a smallpox vaccine in HIV‑infected subjects . J Infect Dis . 2013 ; 207 ( 5 ): 749 – 58 .

Wang X , Gu Z , Sheng S , Song R , Jin R . The current state and progress of monkeypox vaccine research . China CDC Wkly . 2024 ; 6 ( 7 ): 118 – 25 .

Fogg CN , Americo JL , Lustig S , Huggins JW , Smith SK , Damon I , et al . Adjuvant‑enhanced antibody responses to recombinant proteins corre‑late with protection of mice and monkeys to orthopoxvirus challenges . Vaccine . 2007 ; 25 ( 15 ): 2787 – 99 .

Buchman GW , Cohen ME , Xiao Y , Richardson‑Harman N , Silvera P , DeTolla LJ , et al . A protein‑based smallpox vaccine protects non‑human primates from a lethal monkeypox virus challenge . Vaccine . 2010 ; 28 ( 40 ): 6627 – 36 .

Benhnia MR , McCausland MM , Moyron J , Laudenslager J , Granger S , Rickert S , et al . Vaccinia virus extracellular enveloped virion neutraliza‑tion in vitro and protection in vivo depend on complement . J Virol . 2009 ; 83 ( 3 ): 1201 – 15 .

Benhnia MR , McCausland MM , Laudenslager J , Granger SW , Rickert S , Koriazova L , et al . Heavily isotype‑dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5 . J Virol . 2009 ; 83 ( 23 ): 12355 – 67 .

Tang D , Liu X , Lu J , Fan H , Xu X , Sun K , et al . Recombinant proteins A29L, M1R, A35R, and B6R vaccination protects mice from monkeypox virus challenge . Front Immunol . 2023 ; 14 : 1203410 .

Yang X , Yang X , Du S , Hu C , Yang X , Wang X , et al . A subunit vaccine candidate composed of monkeypox virus A29L, M1R, A35R, and B6R elicits robust immune response in mice . Vaccines . 2023 ; 11 ( 9 ): 1420 .

Lin W , Shen C , Li M , Ma S , Liu C , Huang J , et al . Programmable mac‑rophage vesicle based bionic self‑adjuvanting vaccine for immuniza‑tion against monkeypox virus . Adv Sci . 2025 ; 12 ( 1 ): e2408608 .

Wang H , Yin P , Zheng T , Qin L , Li S , Han P , et al . Rational design of a‘two‑in‑one’ immunogen dam drives potent immune response against monkeypox virus . Nat Immunol . 2024 ; 25 ( 2 ): 307 – 15 .

Zhang L . Multi‑epitope vaccines: a promising strategy against tumors and viral infections . Cell Mol Immunol . 2018 ; 15 ( 2 ): 182 – 4 .

Tiwary P , Oswal K , Varghese R , Anchan H , Oswal M . Multi‑epitope vac‑cines: charting a new frontier in monkeypox prevention and control . Hum Cell . 2025 ; 38 ( 5 ): 126 .

Oli AN , Obialor WO , Ifeanyichukwu MO , Odimegwu DC , Okoyeh JN , Emechebe GO , et al . Immunoinformatics and vaccine development: an overview . Immunotargets Ther . 2020 ; 9 : 13 – 30 .

Bidmos FA , Siris S , Gladstone CA , Langford PR . Bacterial vaccine antigen discovery in the reverse vaccinology 2.0 era: progress and challenges . Front Immunol . 2018 ; 9 : 2315 .

Tan C , Zhu F , Pan P , Wu A , Li C . Development of multi‑epitope vaccines against the monkeypox virus based on envelope proteins using immu‑noinformatics approaches . Front Immunol . 2023 ; 14 : 1112816 .

Roberts KL , Smith GL . Vaccinia virus morphogenesis and dissemination . Trends Microbiol . 2008 ; 16 ( 10 ): 472 – 9 .

Suleman M , Rashid F , Ali S , Sher H , Luo S , Xie L , et al . Immunoinformatic‑based design of immune‑boosting multiepitope subunit vaccines against monkeypox virus and validation through molecular dynamics and immune simulation . Front Immunol . 2022 ; 13 : 1042997 .

Yousaf M , Ismail S , Ullah A , Bibi S . Immuno‑informatics profiling of monkeypox virus cell surface binding protein for designing a next‑generation multi‑valent peptide‑based vaccine . Front Immunol . 2022 ; 13 : 1035924 .

Shantier SW , Mustafa MI , Abdelmoneim AH , Fadl HA , Elbager SG , Makhawi AM . Novel multi epitope‑based vaccine against monkeypox virus: vaccinomic approach . Sci Rep . 2022 ; 12 ( 1 ): 15983 .

Sanami S , Nazarian S , Ahmad S , Raeisi E , Tahir Ul Qamar M , Tahmase‑bian S , et al . In silico design and immunoinformatics analysis of a universal multi‑epitope vaccine against monkeypox virus . PLoS ONE . 2023 ; 18 ( 5 ): e0286224 .

de Araújo LP , de Melo Santos NC , Corsetti PP , de Almeida LA . Immuno‑informatic approach for rational identification of immunogenic pep‑tides against host entry and/or exit monkeypox proteins and potential multiepitope vaccine construction . J Infect Dis . 2024 ; 229 ( Supplement_2 ): S285 – 92 .

Sette A , Rappuoli R . Reverse vaccinology: developing vaccines in the era of genomics . Immunity . 2010 ; 33 ( 4 ): 530 – 41 .

Jin Y , Fayyaz A , Liaqat A , Khan A , Alshammari A , Wang Y , et al . Prot‑eomics‑based vaccine targets annotation and design of subunit and mRNA‑based vaccines for monkeypox virus (mpxv) against the recent outbreak . Comput Biol Med . 2023 ; 159 : 106893 .

Singh S , Rao A , Kumar K , Mishra A , Prajapati VK . Translational vaccinom‑ics and structural filtration algorithm to device multiepitope vaccine for catastrophic monkeypox virus . Comput Biol Med . 2023 ; 153 : 106497 .

Waqas M , Aziz S , Liò P , Khan Y , Ali A , Iqbal A , et al . Immunoinformatics design of multivalent epitope vaccine against monkeypox virus and its variants using membrane‑bound, enveloped, and extracellular proteins as targets . Front Immunol . 2023 ; 14 : 1091941 .

Aiman S , Alhamhoom Y , Ali F , Rahman N , Rastrelli L , Khan A , et al . Multi‑epitope chimeric vaccine design against emerging monkeypox virus via reverse vaccinology techniques‑a bioinformatics and immunoinfor‑matics approach . Front Immunol . 2022 ; 13 : 985450 .

Akhtar N , Kaushik V , Grewal RK , Wani AK , Suwattanasophon C , Choowongkomon K , et al . Immunoinformatics‑aided design of a peptide based multiepitope vaccine targeting glycoproteins and mem‑brane proteins against monkeypox virus . Viruses . 2022 ; 14 ( 11 ): 2374 .

Hammarlund E , Dasgupta A , Pinilla C , Norori P , Früh K , Slifka MK . Monkeypox virus evades antiviral CD4 + and CD8 + T cell responses by suppressing cognate T cell activation . Proc Natl Acad Sci USA . 2008 ; 105 ( 38 ): 14567 – 72 .

Pritam M . Exploring the whole proteome of monkeypox virus to design B‑cell epitope‑based oral vaccines using immunoinformatics approaches . Int J Biol Macromol . 2023 ; 252 : 126498 .

Swetha RG , Basu S , Ramaiah S , Anbarasu A . Multi‑epitope vaccine for monkeypox using pan‑genome and reverse vaccinology approaches . Viruses . 2022 ; 14 ( 11 ): 2504 .

Alsaiari AA , Hakami MA , Alotaibi BS , Alkhalil SS , Alkhorayef N , Khan K , et al . Delineating multi‑epitope vaccine designing from membrane protein CL5 against all monkeypox strains: a pangenome reverse vac‑cinology approach . J Biomol Struct Dyn . 2024 ; 42 ( 16 ): 8385 – 406 .

Bloch EM , Sullivan DJ , Shoham S , Tobian AAR , Casadevall A , Gebo KA . The potential role of passive antibody‑based therapies as treatments for monkeypox . MBio . 2022 ; 13 ( 6 ): e0286222 .

Thet AK , Kelly PJ , Kasule SN , Shah AK , Chawala A , Latif A , et al . The use of vaccinia immune globulin in the treatment of severe monkeypox. Virus infection in human immunodeficiency virus/aids . Clin Infect Dis . 2023 ; 76 ( 9 ): 1671 – 3 .

Gu X , Zhang Y , Jiang W , Wang D , Lu J , Gu G , et al . Protective human anti‑poxvirus monoclonal antibodies are generated from rare memory B cells isolated by multicolor antigen tetramers . Vaccines . 2022 ; 10 ( 7 ): 1084 .

Wittek R . Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy . Int J Infect Dis . 2006 ; 10 ( 3 ): 193 – 201 .

Xiao Y , Isaacs SN . Therapeutic vaccines and antibodies for treatment of orthopoxvirus infections . Viruses . 2010 ; 2 ( 10 ): 2381 – 403 .

Bell E , Shamim M , Whitbeck JC , Sfyroera G , Lambris JD , Isaacs SN . Anti‑bodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin . Virology . 2004 ; 325 ( 2 ): 425 – 31 .

Shchelkunov SN , Totmenin AV , Babkin IV , Safronov PF , Ryazankina OI , Petrov NA , et al . Human monkeypox and smallpox viruses: genomic comparison . FEBS Lett . 2001 ; 509 ( 1 ): 66 – 70 .

Guarner J , Del Rio C , Malani PN . Monkeypox in 2022‑what clinicians need to know . JAMA . 2022 ; 328 ( 2 ): 139 – 40 .

Piparva KG , Fichadiya N , Joshi T , Malek S . Monkeypox: from emerging trends to therapeutic concerns . Cureus . 2024 ; 16 ( 4 ): e58866 .

Khalil A , Samara A , O’Brien P , Ladhani SN . Treatment and prevention of monkeypox in pregnant people and young children . Lancet Infect Dis . 2023 ; 23 ( 4 ): 396 – 7 .

Khalil A , Samara A , O’Brien P , Coutinho CM , Duarte G , Quintana SM , et al . Monkeypox in pregnancy: update on current outbreak . Lancet Infect Dis . 2022 ; 22 ( 11 ): 1534 – 5 .

Parker S , D’Angelo J , Buller RM , Smee DF , Lantto J , Nielsen H , et al . A human recombinant analogue to plasma‑derived vaccinia immuno‑globulin prophylactically and therapeutically protects against lethal orthopoxvirus challenge . Antivir Res . 2021 ; 195 : 105179 .

Mitchell LS , Colwell LJ . Analysis of nanobody paratopes reveals greater diversity than classical antibodies . Protein Eng Des Sel . 2018 ; 31 ( 7–8 ): 267 – 75 .

Liu W , Song H , Chen Q , Yu J , Xian M , Nian R , et al . Recent advances in the selection and identification of antigen‑specific nanobodies . Mol Immunol . 2018 ; 96 : 37 – 47 .

Allegra A , Innao V , Gerace D , Vaddinelli D , Allegra AG , Musolino C . Nano‑bodies and cancer: current status and new perspectives . Cancer Invest . 2018 ; 36 ( 4 ): 221 – 37 .

Yu H , Mao G , Pei Z , Cen J , Meng W , Wang Y , et al . In vitro affinity matura‑tion of nanobodies against monkeypox virus A29 protein based on computer‑aided design . Molecules . 2023 ; 28 ( 19 ): 6838 .

Wolffe EJ , Vijaya S , Moss B . A myristylated membrane protein encoded by the vaccinia virus l1r open reading frame is the target of potent neutralizing monoclonal antibodies . Virology . 1995 ; 211 ( 1 ): 53 – 63 .

McNulty MJ , Nandi S , McDonald KA . Technoeconomic modeling and simulation for plant‑based manufacturing of recombinant proteins . Methods Mol Biol . 2022 ; 2480 : 159 – 89 .

Nandi S , Kwong AT , Holtz BR , Erwin RL , Marcel S , McDonald KA . Techno‑economic analysis of a transient plant‑based platform for monoclonal antibody production . MAbs . 2016 ; 8 ( 8 ): 1456 – 66 .

Chen Q . Glycoengineering of plants yields glycoproteins with poly‑sialylation and other defined N‑glycoforms . Proc Natl Acad Sci USA . 2016 ; 113 ( 34 ): 9404 – 6 .

Pereira NA , Chan KF , Lin PC , Song Z . The, “less‑is‑more” in therapeu‑tic antibodies: afucosylated anti‑cancer antibodies with enhanced antibody‑dependent cellular cytotoxicity . MAbs . 2018 ; 10 ( 5 ): 693 – 711 .

Marusic C , Pioli C , Stelter S , Novelli F , Lonoce C , Morrocchi E , et al . N‑glycan engineering of a plant‑produced anti‑CD20‑HIL‑2 immunocy‑tokine significantly enhances its effector functions . Biotechnol Bioeng . 2018 ; 115 ( 3 ): 565 – 76 .

Matho MH , Schlossman A , Meng X , Benhnia MR , Kaever T , Buller M , et al . Structural and functional characterization of anti‑A33 antibodies reveal a potent cross‑species orthopoxviruses neutralizer . PLoS Pathog . 2015 ; 11 ( 9 ): e1005148 .

Chen Z , Earl P , Americo J , Damon I , Smith SK , Yu F , et al . Characterization of chimpanzee/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection model . J Virol . 2007 ; 81 ( 17 ): 8989 – 95 .

Chen Z , Earl P , Americo J , Damon I , Smith SK , Zhou YH , et al . Chimpan‑zee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus . Proc Natl Acad Sci U S A . 2006 ; 103 ( 6 ): 1882 – 7 .

Saadh MJ , Ghadimkhani T , Soltani N , Abbassioun A , Daniel Cosme Pecho R , Taha A , et al . Progress and prospects on vaccine development against monkeypox infection . Microb Pathog . 2023 ; 180 : 106156 .

Mucker EM , Wollen‑Roberts SE , Kimmel A , Shamblin J , Sampey D , Hooper JW . Intranasal monkeypox marmoset model: prophylactic antibody treatment provides benefit against severe monkeypox virus disease . PLoS Negl Trop Dis . 2018 ; 12 ( 6 ): e0006581 .

Mucker EM , Thiele‑Suess C , Baumhof P , Hooper JW . Lipid nanoparti‑cle delivery of unmodified mRNAs encoding multiple monoclonal antibodies targeting poxviruses in rabbits . Mol Ther Nucleic Acids . 2022 ; 28 : 847 – 58 .

Chi H , Zhao SQ , Chen RY , Suo XX , Zhang RR , Yang WH , et al . Rapid devel‑opment of double‑hit mRNA antibody cocktail against orthopoxviruses . Signal Transduct Target Ther . 2024 ; 9 ( 1 ): 69 .

Wang W , Mo W , Xiao X , Cai M , Feng S , Wang Y , et al . Antibiotic‑loaded lactoferrin nanoparticles as a platform for enhanced infection therapy through targeted elimination of intracellular bacteria . Asian J Pharm Sci . 2024 ; 19 ( 4 ): 100926 .

Zhang L , Huang J , Buratto D , Han P , Yang Z , Zhou R . A pH‑responsive nanoparticle delivery system containing dihydralazine and doxoru‑bicin‑based prodrug for enhancing antitumor efficacy . Aggregate . 2023 ; 5 ( 1 ): e434 .

Wang W , Guo H , Lin S , Xiao X , Liu Y , Wang Y , et al . Biosafety materials for tuberculosis treatment . Biosaf Health . 2022 ; 4 ( 4 ): 258 – 68 .

Hagedorn L , Jürgens DC , Merkel OM , Winkeljann B . Endosomal escape mechanisms of extracellular vesicle‑based drug carriers: lessons for lipid nanoparticle design . Extracell Vesicles Circ Nucl Acids . 2024 ; 5 ( 3 ): 344 – 57 .

Liang F , An X , Wang R , Wu W , Yang L , Zheng Y , et al . Microalgae‑based drug delivery system for tumor microenvironment photo‑modulating and synergistic chemo‑photodynamic therapy of osteosarcoma . Eng Regen . 2024 ; 5 ( 2 ): 199 – 209 .

Huang H , Lang Y , Wang S , Zhou M . Microalgae‑based drug delivery systems in biomedical applications . Eng Regen . 2024 ; 5 ( 3 ): 361 – 74 .

Wu Y , Liu Y , Wang T , Jiang Q , Xu F , Liu Z . Living cell for drug delivery . Eng Regen . 2022 ; 3 ( 2 ): 131 – 48 .

Ijaz M , Hasan I , Chaudhry TH , Huang R , Zhang L , Hu Z , et al . Bacterial derivatives mediated drug delivery in cancer therapy: a new generation strategy . J Nanobiotechnol . 2024 ; 22 ( 1 ): 510 .

He S , Fu Y , Tan Z , Jiang Q , Huang K , Saw PE , et al . Optimization of ultra‑small nanoparticles for enhanced drug delivery . BIO Integration . 2023 ; 4 ( 2 ): 62 – 9 .

Wang F , Li Z . Engineered extracellular vesicles as “supply vehi‑cles” to alleviate type 1 diabetes . Extracell Vesicles Circ Nucl Acids . 2024 ; 5 ( 4 ): 618 – 21 .

Liu H , Song P , Zhang H , Zhou F , Ji N , Wang M , et al . Synthetic biology‑based bacterial extracellular vesicles displaying BMP‑2 and CXCR‑4 to ameliorate osteoporosis . J Extracell Vesicles . 2024 ; 13 ( 4 ): e12429 .

Liu H , Zhang Q , Wang S , Weng W , Jing Y , Su J . Bacterial extracellular vesicles as bioactive nanocarriers for drug delivery: advances and perspectives . Bioact Mater . 2022 ; 14 : 169 – 81 .

Pantaleo G , Correia B , Fenwick C , Joo VS , Perez L . Antibodies to combat viral infections: development strategies and progress . Nat Rev Drug Discov . 2022 ; 21 ( 9 ): 676 – 96 .

Garegnani L , Styrmisdóttir L , Roson Rodriguez P , Escobar Liquitay CM , Esteban I , Franco JV . Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children . Cochrane Database Syst Rev . 2021 ; 11 ( 11 ): Cd013757 .

Li B , Wang W , Zhao L , Li M , Yan D , Li X , et al . Aggregation‑induced emission‑based macrophage‑like nanoparticles for targeted photother‑mal therapy and virus transmission blockage in monkeypox . Adv Mater . 2024 ; 36 ( 9 ): e2305378 .

Wang C , Lv S , Sun Z , Xiao M , Fu H , Tian L , et al . A self‑regulated pho‑totheranostic nanosystem with single wavelength‑triggered energy switching and oxygen supply for multimodal synergistic therapy of bacterial biofilm infections . Aggregate . 2024 ; 5 ( 5 ): e587 .

Li X , Wang W , Gao Q , Lai S , Liu Y , Zhou S , et al . Intelligent bacteria‑target‑ing ZIF‑8 composite for fluorescence imaging‑guided photodynamic therapy of drug‑resistant superbug infections and burn wound healing . Exploration . 2024 ; 4 ( 6 ): 20230113 .

Li B , Wang W , Zhao L , Wu Y , Li X , Yan D , et al . Photothermal therapy of tuberculosis using targeting pre‑activated macrophage membrane‑coated nanoparticles . Nat Nanotechnol . 2024 ; 19 ( 6 ): 834 – 45 .

Chen L , Wang X , Yuan Y , Hu R , Chen Q , Zhu L , et al . Photosensitizers with aggregation‑induced emission and their biomedical applications . Eng Regen . 2022 ; 3 ( 1 ): 59 – 72 .

Li B , Wang W , Song W , Zhao Z , Tan Q , Zhao Z , et al . Antiviral and anti‑inflammatory treatment with multifunctional alveolar macrophage‑like nanoparticles in a surrogate mouse model of COVID‑19 . Adv Sci . 2021 ; 8 ( 13 ): 2003556 .

Hu Z , Wang W , Lin Y , Guo H , Chen Y , Wang J , et al . Extracellular vesicle‑inspired therapeutic strategies for the COVID‑19 . Adv Healthc Mater . 2024 ; 13 ( 29 ): e2402103 .

Shi R , Zhan A , Li X , Kong B , Liang G . Biomimetic extracellular vesicles for the tumor targeted treatment . Eng Regen . 2023 ; 4 ( 4 ): 427 – 37 .

Jiang L , Xu A , Guan L , Tang Y , Chai G , Feng J , et al . A review of monkey‑pox: biological characteristics, epidemiology, clinical features, diagnosis, treatment, and prevention strategies . Exploration . 2024 ; 5 ( 2 ): 20230112 .

Ma T , Liu D , Lyu K , Gao T , Shi D , Zhao L , et al . Establishment and applica‑tion of national reference panels for SARS‑CoV‑2 antigen detection kit . Biosaf Health . 2023 ; 5 ( 6 ): 326 – 30 .

Zhou H , Wang C , Rao J , Chen L , Ma T , Liu D , et al . The impact of sample processing on the rapid antigen detection test for SARS‑CoV‑2: virus inactivation, VTM selection, and sample preservation . Biosaf Health . 2021 ; 3 ( 5 ): 238 – 43 .

Forgham H , Kakinen A , Qiao R , Davis TP . Keeping up with the COVID’s—Could siRNA‑based antivirals be a part of the answer? Exploration . 2022 ; 2 ( 6 ): 20220012 .

Kubiatowicz LJ , Mohapatra A , Krishnan N , Fang RH , Zhang L . mRNA nanomedicine: design and recent applications . Exploration . 2022 ; 2 ( 6 ): 20210217 .

Wang Z , Cui K , Costabel U , Zhang X . Nanotechnology‑facilitated vac‑cine development during the coronavirus disease 2019 (COVID‑19)pandemic . Exploration . 2022 ; 2 ( 5 ): 20210082 .

Huang Y , Mu L , Wang W . Monkeypox: epidemiology, pathogenesis, treatment and prevention . Signal Transduct Target Ther . 2022 ; 7 ( 1 ): 373 .

Taub DD , Ershler WB , Janowski M , Artz A , Key ML , McKelvey J , et al . Immunity from smallpox vaccine persists for decades: a longitudinal study . Am J Med . 2008 ; 121 ( 12 ): 1058 – 64 .

Viner KM , Isaacs SN . Activity of vaccinia virus‑neutralizing antibody in the sera of smallpox vaccinees . Microbes Infect . 2005 ; 7 ( 4 ): 579 – 83 .

Bankuru SV , Kossol S , Hou W , Mahmoudi P , Rychtář J , Taylor D . A game‑theoretic model of monkeypox to assess vaccination strategies . PeerJ . 2020 ; 8 : e9272 .

Pagant S , Liberatore RA . In vivo electroporation of plasmid DNA: a promising strategy for rapid, inexpensive, and flexible delivery of anti‑viral monoclonal antibodies . Pharmaceutics . 2021 ; 13 ( 11 ): 1882 .

Babalola BA , Akinsuyi OS , Folajimi EO , Olujimi F , Otunba AA , Chikere B , et al . Exploring the future of SARS‑CoV‑2 treatment after the first 2 years of the pandemic: a comparative study of alternative therapeutics . Biomed Pharmacother . 2023 ; 165 : 115099 .

Sun H , Chen Q , Lai H . Development of antibody therapeutics against flaviviruses . Int J Mol Sci . 2017 ; 19 ( 1 ): 54 .

de Almeida Oliveira A , Praia Borges Freire D , Rodrigues de Andrade A , de Miranda Marques A , da Silva Madeira L , Moreno Senna JP , et al . The landscape of neutralizing monoclonal antibodies (nAbs) for treatment and prevention of COVID‑19 . J Pharm Innov . 2023 : 1 – 19 .

Nezvalova‑Henriksen K , Langebrake C , Bauters T , Moreno‑Martinez ME , Ahnfelt E , Ekelund H , et al . Implementation and operational manage‑ment of marketed chimeric antigen receptor T cell (CAR‑T cell) therapy‑a guidance by the GOCART Coalition pharmacist working group . Bone Marrow Transplant . 2023 ; 58 ( 10 ): 1069 – 74 .

Faulkner L , Verna M , Rovelli A , Agarwal RK , Dhanya R , Parmar L , et al . Setting up and sustaining blood and marrow transplant services for children in middle‑income economies: an experience‑driven posi‑tion paper on behalf of the EBMT . PDWP Bone Marrow Transplant . 2021 ; 56 ( 3 ): 536 – 43 .

Barocas JA , Strathdee SA . Beyond sex: human monkeypox virus is an emerging threat to marginalized populations . Open Forum Infect Dis . 2022 ; 9 ( 11 ): ofac551 .

Suárez Rodríguez B , Guzmán Herrador BR , Díaz Franco A , Sánchez‑Seco Fariñas MP , Del Amo VJ , Aginagalde Llorente AH , et al . Epidemiologic features and control measures during monkeypox outbreak, Spain, June 2022 . Emerg Infect Dis . 2022 ; 28 ( 9 ): 1847 – 51 .

Potet J , Beran D , Ray N , Alcoba G , Habib AG , Iliyasu G , et al . Access to antivenoms in the developing world: a multidisciplinary analysis . Toxicon X . 2021 ; 12 : 100086 .

Johri N , Kumar D , Nagar P , Maurya A , Vengat M , Jain P . Clinical manifes‑tations of human monkeypox infection and implications for outbreak strategy . Health Sci Rev . 2022 ; 5 : 100055 .

Crosato V , Formenti B , Gulletta M , Odolini S , Compostella S , Tomasoni LR , et al . Perception and awareness about monkeypox and vaccination acceptance in an at‑risk population in Brescia, Italy: an investigative survey . AIDS Behav . 2024 ; 28 ( 5 ): 1594 – 600 .

Lulli LG , Baldassarre A , Mucci N , Arcangeli G . Prevention, risk exposure, and knowledge of monkeypox in occupational settings: a scoping review . Trop Med Infect Dis . 2022 ; 7 ( 10 ): 276 .

Zardi EM , Chello C . Human monkeypox global public health emer‑gency . Int J Environ Res Public Health . 2022 ; 19 ( 24 ): 16781 .

Hirani R , Rashid D , Lewis J , Hosein‑Woodley R , Issani A . Monkeypox outbreak in the age of COVID‑19: a new global health emergency . Mil Med Res . 2022 ; 9 ( 1 ): 55 .

Wallau GL , Maciel‑de‑Freitas R , Schmidt‑Chanasit J . An unfolding monk‑eypox outbreak in Europe and beyond . Mil Med Res . 2022 ; 9 ( 1 ): 31 .

Sun N , Meng X , Liu Y , Song D , Jiang C , Cai J . Applications of brain orga‑noids in neurodevelopment and neurological diseases . J Biomed Sci . 2021 ; 28 ( 1 ): 30 .